Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans.
Kent SJ, Li S, Amarasena TH, Reynaldi A, Lee WS, Leeming MG, O'Connor DH, Nguyen J, Kent HE, Caruso F, Juno JA, Wheatley AK, Davenport MP, Ju Y. Kent SJ, et al. Among authors: kent he. ACS Nano. 2024 Oct 1;18(39):27077-27089. doi: 10.1021/acsnano.4c11652. Epub 2024 Sep 19. ACS Nano. 2024. PMID: 39298422 Free PMC article.
Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.
Wheatley AK, Juno JA, Wang JJ, Selva KJ, Reynaldi A, Tan HX, Lee WS, Wragg KM, Kelly HG, Esterbauer R, Davis SK, Kent HE, Mordant FL, Schlub TE, Gordon DL, Khoury DS, Subbarao K, Cromer D, Gordon TP, Chung AW, Davenport MP, Kent SJ. Wheatley AK, et al. Among authors: kent sj, kent he. Nat Commun. 2021 Feb 19;12(1):1162. doi: 10.1038/s41467-021-21444-5. Nat Commun. 2021. PMID: 33608522 Free PMC article.
Tear antibodies to SARS-CoV-2: implications for transmission.
Selva KJ, Davis SK, Haycroft ER, Lee WS, Lopez E, Reynaldi A, Davenport MP, Kent HE, Juno JA, Chung AW, Kent SJ. Selva KJ, et al. Among authors: kent sj, kent he. Clin Transl Immunology. 2021 Nov 1;10(11):e1354. doi: 10.1002/cti2.1354. eCollection 2021. Clin Transl Immunology. 2021. PMID: 34754451 Free PMC article.
Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory.
Wragg KM, Lee WS, Koutsakos M, Tan HX, Amarasena T, Reynaldi A, Gare G, Konstandopoulos P, Field KR, Esterbauer R, Kent HE, Davenport MP, Wheatley AK, Kent SJ, Juno JA. Wragg KM, et al. Among authors: kent he. Nat Immunol. 2022 May;23(5):768-780. doi: 10.1038/s41590-022-01175-5. Epub 2022 Mar 21. Nat Immunol. 2022. PMID: 35314848
The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.
Koutsakos M, Lee WS, Reynaldi A, Tan HX, Gare G, Kinsella P, Liew KC, Taiaroa G, Williamson DA, Kent HE, Stadler E, Cromer D, Khoury DS, Wheatley AK, Juno JA, Davenport MP, Kent SJ. Koutsakos M, et al. Among authors: kent he. Immunity. 2022 Jul 12;55(7):1316-1326.e4. doi: 10.1016/j.immuni.2022.05.018. Epub 2022 May 27. Immunity. 2022. PMID: 35690062 Free PMC article.
SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses.
Koutsakos M, Reynaldi A, Lee WS, Nguyen J, Amarasena T, Taiaroa G, Kinsella P, Liew KC, Tran T, Kent HE, Tan HX, Rowntree LC, Nguyen THO, Thomas PG, Kedzierska K, Petersen J, Rossjohn J, Williamson DA, Khoury D, Davenport MP, Kent SJ, Wheatley AK, Juno JA. Koutsakos M, et al. Among authors: kent he. Immunity. 2023 Apr 11;56(4):879-892.e4. doi: 10.1016/j.immuni.2023.02.017. Epub 2023 Feb 28. Immunity. 2023. PMID: 36958334 Free PMC article.
Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection.
Lee WS, Tan HX, Reynaldi A, Esterbauer R, Koutsakos M, Nguyen J, Amarasena T, Kent HE, Aggarwal A, Turville SG, Taiaroa G, Kinsella P, Liew KC, Tran T, Williamson DA, Cromer D, Davenport MP, Kent SJ, Juno JA, Khoury DS, Wheatley AK. Lee WS, et al. Among authors: kent he. Sci Adv. 2023 Jul 21;9(29):eadg5301. doi: 10.1126/sciadv.adg5301. Epub 2023 Jul 21. Sci Adv. 2023. PMID: 37478181 Free PMC article.
Mucosal antibody responses following Vaxzevria vaccination.
Selva KJ, Ramanathan P, Haycroft ER, Tan CW, Wang LF, Downie LE, Davis SK, Purcell RA, Kent HE, Juno JA, Wheatley AK, Davenport MP, Kent SJ, Chung AW. Selva KJ, et al. Among authors: kent he. Immunol Cell Biol. 2023 Nov-Dec;101(10):975-983. doi: 10.1111/imcb.12685. Epub 2023 Sep 5. Immunol Cell Biol. 2023. PMID: 37670482 Free PMC article.
Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections.
Selva KJ, Ramanathan P, Haycroft ER, Reynaldi A, Cromer D, Tan CW, Wang LF, Wines BD, Hogarth PM, Downie LE, Davis SK, Purcell RA, Kent HE, Juno JA, Wheatley AK, Davenport MP, Kent SJ, Chung AW. Selva KJ, et al. Among authors: kent he. JCI Insight. 2023 Sep 22;8(18):e172470. doi: 10.1172/jci.insight.172470. JCI Insight. 2023. PMID: 37737263 Free PMC article.
Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine.
Lee WS, Audsley J, Trieu MC, Reynaldi A, Aurelia LC, Mehta PH, Patterson J, Kent HE, Nguyen J, Amarasena T, Esterbauer R, Haycroft ER, Ramanathan P, Davenport MP, Schlub TE, Sasadeusz J, Wheatley AK, Chung AW, Juno JA, Selva KJ, Kent SJ. Lee WS, et al. Among authors: kent he. J Clin Invest. 2024 Jul 11;134(17):e181244. doi: 10.1172/JCI181244. J Clin Invest. 2024. PMID: 38990644 Free PMC article. Clinical Trial.
18 results